Horizon scanning: Lenalidomide on fast-track review by the USFDA for mantle cell lymphoma

Source: Reuters Health News Area: News According to a report by Reuters Health News, the US Food and Drug Administration (FDA) has granted priority review for lenalidomide used for the treatment of relapsed or refractory mantle cell lymphoma
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news